CGTX: FDA Agrees On Outcome
Cognition Therapeutics reaches alignment with FDA on vital aspects to support its new drug application for psychosis associated with dementia with Lewy bodies
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Cognition Therapeutics reaches alignment with FDA on vital aspects to support its new drug application for psychosis associated with dementia with Lewy bodies